Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA Guidance Emphasizes Randomized, Blinded Trials For PMAs

Aug 22 2011

Related Content

Research Backlash: Does FDA Have A PMA Problem?

Jan 18 2010

Two Reviews Question Quality Of Cardiac PMA Trials

Jan 04 2010

Risk-Benefit Guidance Aims To Improve Pre-Market Review Predictability

Aug 22 2011

Additional Topics

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window